SCHEMBL1964058

SCHEMBL1964058

c1ccc(NOc2cccc(ONc3ccccc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
AR P10275 1/20 0.42
MAPT P10636 1/20 0.42
HCRTR1 O43613 1/20 0.41
HSD17B10 Q99714 3/20 0.38
TSHR P16473 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
LTA4H P09960 1/20 0.38
CTSD P07339 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
CYP1A2 P05177 2/20 0.37
HTT P42858 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28470357 0.94 MAOB (0.45) ALDH1A1KMT2AMEN1ARMAPT
SCHEMBL29739285 0.94 MAOB (0.45) ALDH1A1KMT2AMEN1ARMAPT
SCHEMBL25386742 0.90 HCRTR1 (0.54) KMT2AMEN1MAPTHCRTR1TSHR
SCHEMBL30567223 0.90 HCRTR1 (0.54) KMT2AMEN1MAPTHCRTR1TSHR
SCHEMBL251644 0.87 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1ARMAPT
SCHEMBL11552332 0.86 KMT2A (0.35) ALDH1A1KMT2AMEN1ARMAPT
SCHEMBL29006127 0.86 MAOB (0.57) ALDH1A1KMT2AMEN1MAPTTSHR
SCHEMBL633343 0.86 CYP1A2 (0.54) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL7993466 0.86 NPSR1 (0.52) ALDH1A1KMT2AMEN1MAPTCYP1A2
SCHEMBL7885157 0.86 KMT2A (0.54) ALDH1A1KMT2AMEN1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144709-A1 PREPARATION AND APPLICATION OF POLYIMIDE INTERMEDIATES FOR ANTI-CORROSION COATING ON METAL SURFACES TATA STEEL LIMITED (IN) 2023-08-03 WO claimed
CN-113121824-B Polyimide film, polyimide composition, and display screen element 株式会社东进世美肯 2025-03-18 CN disclosed
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-15 US disclosed
CN-113039237-B Polyimide film, polyimide composition, and method for producing film using same 株式会社东进世美肯 2023-12-15 CN disclosed
CN-113121879-B Bismaleimide cross-linking agent for low loss dielectrics 罗门哈斯电子材料有限责任公司 2023-05-23 CN disclosed
EP-4055088-A1 COMPOSITION AND METHOD FOR MANUFACTURING RESINS Cambium Biomaterials, Inc. (US) 2022-09-14 EP disclosed
CN-109478015-B Organic layer composition and pattern forming method 三星SDI株式会社 2022-04-12 CN disclosed
CN-108884023-B Bisphenol M bisphthalonitrile ether resin, bisphenol P bisphthalonitrile ether resin, preparation methods thereof, resin blend and two-component system 3M创新有限公司 2022-02-25 CN disclosed
CN-113121879-A Bismaleimide crosslinkers for low loss dielectrics 罗门哈斯电子材料有限责任公司 2021-07-16 CN disclosed
US-20190210768-A1 DELAMINATION RESISTANT GLASS CONTAINERS WITH HEAT-TOLERANT COATINGS CORNING INCORPORATED (US) 2019-07-11 US disclosed
US-8557444-B2 Multi-layer article comprising polyimide nanoweb E I DU PONT DE NEMOURS AND COMPANY (US) 2013-10-15 US disclosed
EP-2514003-A2 MULTI-LAYER ARTICLE COMPRISING POLYIMIDE NANOWEB E.I. Du Pont De Nemours And Company (US) 2012-10-24 EP disclosed
EP-2514004-A2 ELECTROCHEMICAL CELL COMPRISING A SEPARATOR COMPRISING A NANOWEB CONSISTING ESSENTIALLY OF NANOFIBERS OF FULLY AROMATIC POLYIMIDE E.I. Du Pont De Nemours And Company (US) 2012-10-24 EP disclosed
EP-2513366-A2 METHOD FOR INCREASING THE STRENGTH AND SOLVENT RESISTANCE OF POLYIMIDE NANOWEBS E.I. Du Pont De Nemours And Company (US) 2012-10-24 EP disclosed
WO-2011081914-A2 METHOD FOR INCREASING THE STRENGTH AND SOLVENT RESISTANCE OF POLYIMIDE NANOWEBS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-07 WO disclosed
WO-2011081879-A2 ELECTROCHEMICAL CELL COMPRISING A SEPARATOR COMPRISING A NANOWEB CONSISTING ESSENTIALLY OF NANOFIBERS OF FULLY AROMATIC POLYIMIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-07 WO disclosed
WO-2011081875-A2 MULTI-LAYER ARTICLE COMPRISING POLYIMIDE NANOWEB E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-07 WO disclosed
US-20110143217-A1 ELECTROCHEMICAL CELL COMPRISING A SEPARATOR COMPRISING A NANOWEB CONSISTING ESSENTIALLY OF NANOFIBERS OF FULLY AROMATIC POLYIMIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-16 US disclosed
US-20110139331-A1 METHOD FOR INCREASING THE STRENGTH AND SOLVENT RESISTANCE OF POLYIMIDE NANOWEBS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-16 US disclosed
US-20110143207-A1 MULTI-LAYER ARTICLE COMPRISING POLYIMIDE NANOWEB E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TERT, TERB1, MCM5 ALDH1A1 1603/4885KMT2A 735/4885MEN1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.